Please login to the form below
3
Revenue 2017Roche
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.
Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
Lilly entered into a partnership with Roche last week to develop a blood test for Alzheimer’s disease which, if approved, could help streamline the journey to diagnosis for more patients.
Targacept picks Solvay's Stephen Hill to fill vacant CEO post
Prior to that, he served at US biotech ArQule and Roche, where he held several leadership positions including global head of clinical development.
HTA guidance from NICE, the SMC and the AWMSG
data. Prior to the SMC’s decision,. 2 Feb 2023. Roche’s Polivy (polatuzumab vedotin) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of
Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
Roche has announced a partnership with Eli Lilly aimed at developing a blood test for Alzheimer’s disease which, if approved, could help streamline the journey to diagnosis for more patients. ... Matt Sause, chief executive officer of Roche Diagnostics,
Roche launches two antibodies to identify mutation status in brain cancer patients
Roche has announced the launch of two new antibodies to identify key mutations in patients diagnosed with brain cancer, allowing clinicians to quickly determine the best treatment path for a specific ... Knowing a patient’s IDH1 and ATRX mutation
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- AstraZeneca’s mild combination asthma reliever approved in UK
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- When to call in the specialists: strategy in Medical Affairs
- Time to talk about health inequalities
- Powering Rapid Cognitive Analysis with AI
- AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Janssen’s single tablet combination shows promise in phase 3 PAH study
- How to make sure your adverts for clinical trials are compliant
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
Latest intelligence
- Time to talk about health inequalities
- Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
- The speed of science and the pace of comms
- Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
